Supplementary Figure S7 from Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Supplementary Figure S7 shows the dose- and time-dependent inhibition of DUSP6 and pERK in KRAS-mutant CDX models treated with BBO-11818, as well as the mean body weight in a KRASG12D CDX model treated with BBO-11818.
Fields of Study & Subjects
Protein Kinase Regulation and GTPase Signaling
Melanoma and MAPK Pathways
Protein Tyrosine Phosphatases
Publication details
- Publication date
- 1 April 2026
- Language
- EN